731 related articles for article (PubMed ID: 9384571)
21. Need for caspases in apoptosis of trophic factor-deprived PC12 cells.
Haviv R; Lindenboim L; Li H; Yuan J; Stein R
J Neurosci Res; 1997 Oct; 50(1):69-80. PubMed ID: 9379495
[TBL] [Abstract][Full Text] [Related]
22. Inhibitors of apoptotic proteins: new targets for anticancer therapy.
Saleem M; Qadir MI; Perveen N; Ahmad B; Saleem U; Irshad T; Ahmad B
Chem Biol Drug Des; 2013 Sep; 82(3):243-51. PubMed ID: 23790005
[TBL] [Abstract][Full Text] [Related]
23. Baculovirus p35 and Z-VAD-fmk inhibit thapsigargin-induced apoptosis of breast cancer cells.
Qi XM; He H; Zhong H; Distelhorst CW
Oncogene; 1997 Sep; 15(10):1207-12. PubMed ID: 9294614
[TBL] [Abstract][Full Text] [Related]
24. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.
Roa WH; Chen H; Fulton D; Gulavita S; Shaw A; Th'ng J; Farr-Jones M; Moore R; Petruk K
Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484
[TBL] [Abstract][Full Text] [Related]
25. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases.
Fujita N; Nagahashi A; Nagashima K; Rokudai S; Tsuruo T
Oncogene; 1998 Sep; 17(10):1295-304. PubMed ID: 9771973
[TBL] [Abstract][Full Text] [Related]
26. Neuronal apoptosis-inhibitory protein does not interact with Smac and requires ATP to bind caspase-9.
Davoodi J; Lin L; Kelly J; Liston P; MacKenzie AE
J Biol Chem; 2004 Sep; 279(39):40622-8. PubMed ID: 15280366
[TBL] [Abstract][Full Text] [Related]
27. Baculovirus inhibitors of apoptosis (IAPs) block activation of Sf-caspase-1.
Seshagiri S; Miller LK
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13606-11. PubMed ID: 9391073
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
29. Identification of a caspase-2 isoform that behaves as an endogenous inhibitor of the caspase cascade.
Droin N; Beauchemin M; Solary E; Bertrand R
Cancer Res; 2000 Dec; 60(24):7039-47. PubMed ID: 11156409
[TBL] [Abstract][Full Text] [Related]
30. Ajoene, an experimental anti-leukemic drug: mechanism of cell death.
Dirsch VM; Antlsperger DS; Hentze H; Vollmar AM
Leukemia; 2002 Jan; 16(1):74-83. PubMed ID: 11840266
[TBL] [Abstract][Full Text] [Related]
31. XIAP regulates DNA damage-induced apoptosis downstream of caspase-9 cleavage.
Datta R; Oki E; Endo K; Biedermann V; Ren J; Kufe D
J Biol Chem; 2000 Oct; 275(41):31733-8. PubMed ID: 10930419
[TBL] [Abstract][Full Text] [Related]
32. Involvement of caspase-3 and p38 mitogen-activated protein kinase in cobalt chloride-induced apoptosis in PC12 cells.
Zou W; Zeng J; Zhuo M; Xu W; Sun L; Wang J; Liu X
J Neurosci Res; 2002 Mar; 67(6):837-43. PubMed ID: 11891799
[TBL] [Abstract][Full Text] [Related]
33. Caspases and mitochondria in c-Myc-induced apoptosis: identification of ATM as a new target of caspases.
Hotti A; Järvinen K; Siivola P; Hölttä E
Oncogene; 2000 May; 19(19):2354-62. PubMed ID: 10822387
[TBL] [Abstract][Full Text] [Related]
34. The IAP family: endogenous caspase inhibitors with multiple biological activities.
Yang YL; Li XM
Cell Res; 2000 Sep; 10(3):169-77. PubMed ID: 11032169
[TBL] [Abstract][Full Text] [Related]
35. The BIR domain of IAP-like protein 2 is conformationally unstable: implications for caspase inhibition.
Shin H; Renatus M; Eckelman BP; Nunes VA; Sampaio CA; Salvesen GS
Biochem J; 2005 Jan; 385(Pt 1):1-10. PubMed ID: 15485395
[TBL] [Abstract][Full Text] [Related]
36. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP.
Suzuki A; Tsutomi Y; Akahane K; Araki T; Miura M
Oncogene; 1998 Aug; 17(8):931-9. PubMed ID: 9747872
[TBL] [Abstract][Full Text] [Related]
37. The loss of IAP expression during HL-60 cell differentiation is caspase-independent.
Doyle BT; O'Neill AJ; Newsholme P; Fitzpatrick JM; Watson RW
J Leukoc Biol; 2002 Feb; 71(2):247-54. PubMed ID: 11818445
[TBL] [Abstract][Full Text] [Related]
38. Pharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transport.
Talbott RL; Borzilleri RM; Chaudhry C; Fargnoli J; Shen H; Fairchild C; Barnhart B; Ortega M; McDonagh TE; Vuppugalla R; Vite GD; Hunt JT; Gottardis M; Naglich JG
Exp Cell Res; 2015 Nov; 338(2):251-60. PubMed ID: 26302264
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
[TBL] [Abstract][Full Text] [Related]
40. Endogenously released Smac is insufficient to mediate cell death of human lung carcinoma in response to etoposide.
Bartling B; Lewensohn R; Zhivotovsky B
Exp Cell Res; 2004 Aug; 298(1):83-95. PubMed ID: 15242764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
